Menu
Enrolling by invitation NCT07020975

Virtual Reality for Anxiety Relief in Infertile Women

No phase Interventional Anxiety Assisted Reproductive Treatments Women VR

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: VR Glasses.
Who it may be relevant to
Registry conditions: Anxiety, Assisted Reproductive Treatments, Women, VR. Basic parameters: 18 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Cyprus
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Virtual Reality Application on Anxiety Before and After Embryo Transfer in Infertile Women

Overview

This study examines the impact of virtual reality (VR) applications on anxiety levels before and after embryo transfer procedures. The clinical trial will involve 80 participants, aged 18 to 50, who are receiving treatment at a healthcare facility in the Turkish Republic of Northern Cyprus (TRNC). The primary objective is to evaluate the effectiveness of VR as an intervention for reducing anxiety in individuals undergoing assisted reproductive treatments.

Detailed description

This doctoral study aims to evaluate the use of virtual reality (VR) as an innovative, non-invasive intervention for managing anxiety during embryo transfer in assisted reproductive technology (ART). A randomized clinical trial will be conducted with 80 participants, aged 18 to 50, undergoing fertility treatment at a healthcare facility in the Turkish Republic of Northern Cyprus (TRNC).

Participants will be randomly assigned to one of two groups: the intervention group (n=40), which will experience a VR session both before and after the embryo transfer, and the control group (n=40), which will receive standard care without VR. Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI) at two time points-pre- and post-embryo transfer.

The primary objective of this study is to determine the effectiveness of VR in reducing procedural anxiety, a factor known to negatively affect patient experience and potentially influence treatment outcomes. The findings are expected to support the integration of patient-centered, technology-enhanced strategies in reproductive healthcare practices.

Interventions

  • Device VR Glasses
    VR Glasses is used to help people be in a virtual reality other than their real life. What we use this for; to get away infertile women from her stressfull environment to another virtual reality before their embryo transfer.

Primary outcome measures

  • Anxiety level of the women who went through embryo transfer. [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Volunteered to participate in the research,
  • 18-50 years old
  • No vision and hearing problems,
  • Not disoriented in time and place,
  • Primary infertile
  • Not having communication problem
  • Can read \& write
  • No mental pathological disease

Exclusion criteria

  • Secondary infertility
  • Having experienced bleeding, miscarriage, etc. after embryo transfer,
  • Difficulty communicating,
  • Problems such as migraine, vertigo, dizziness,
  • Patients who wear prescription glasses and have vision problems without glasses
  • Refused to participate in the research
  • Patients with psychiatric pathology

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Cyprus · 1 center
  • Cyprus Aydin University — Girne Kepuveia

Publications

  • Garcia-Palacios A, Hoffman H, Carlin A, Furness TA 3rd, Botella C. Virtual reality in the treatment of spider phobia: a controlled study. Behav Res Ther. 2002 Sep;40(9):983-93. doi: 10.1016/s0005-7967(01)00068-7. PMID 12296495
  • Freeman D, Reeve S, Robinson A, Ehlers A, Clark D, Spanlang B, Slater M. Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychol Med. 2017 Oct;47(14):2393-2400. doi: 10.1017/S003329171700040X. Epub 2017 Mar 22. PMID 28325167

Identifiers

NCT: NCT07020975 · 2025/04.007

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗